References
- Olson RE. A critique of the report of the National Institutes of Health expert panel on detection evaluation and treatment of high blood cholesterol. Arch Intern Med 1989; 149: 1501–1503
- Haber H., Heavy J., Kukn M., Gottlieb S., Packer M. A low serum cholesterol is not a favorable prognostic finding in patients with severe chronic heart failure: A clinical paradox. Circ 1988; 78((II))585, (abstract)
- Rostand S. G., Kirk K. A., Rutsky EA. Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease. Kindey Int 1981; 22: 304–308
- Brunzell J. D., Austin MA. Plasma triglyceride levels and coronary disease. N Engl J Med 1989; 320: 1273–1275
- Avram M. M., Antignani A., Goldwasser P., Fein P. A., Mushnick R., Quinones E., Jorden A., Mittman N. Lipids in diabetic and non-diabetic dialysis patients. Trans Am Soc Artif Intern Organs 1988; 34: 314–316
- Port KP. Mortality and causes of death in patients with end-stage renal disease. Am J Kid Dis 1990; 15: 215–217
- D'Elia J., Weinrauch L., Gleason R., Hampton L., Smith-Ossman S., Yoburn D., Kaldany A., Healy R., Leland O., Jr. Application of the ambulatory 24 hour electrocardiogram in the prediction of cardiac death in dialysis patients. Arch Intern Med 1988; 14: 2381–2385
- Coronel F., Tornero F., Torrente P., Naranjo P., DeOleo P., Macia M., Barrientos A. Treatment of hyperlipidemia in diabetic patients on dialysis with a physiologic substance. Am J Nephrol 1991; 11: 32–26
- Lapuz M., Avram M. M., Lustig A., Goldwasser P., Antignani A., Fein P. A., Mittman N. Fall of cholesterol with time on dialysis: Impact on atherogenicity. Trans Am Soc Artif Intern Organs 1989; 35: 258–260
- Avram M. M., Anignani A., Goldwasser P., Lustig A., Fein P., Mushnick R., Quinones E., Rao Y., Mittman N. Lipids in diabetic and nondiabetic hemodialysis and CAPD patients. Trans Am Soc Artif Intern Organs 1988; 34: 314–316
- Burrell D., Antignani A., Fein P. A., Goldwasser P., Mittman N., Avram MM. Longitudinal survey of apolipoproteins and athero-genic risk in hemodialysis and continuous ambulatory peritoneal dialysis patients. Trans Am Soc Artif Intern Organs 1990; 36: M331–M335
- Larsen J. L., Stratta R. J., Ozaki C. F., Taylor R. J., Miller Duckworth S. A. Lipid status after pancreas-kidney transplantation. Diabetes Care 1992; 15: 35–42
- Zar JH. Biostatistical Analysis (2nd ed.)Englewood Cliffs. Prentice Hall, NJ 1984
- Barr A. J., Goodnight J. A., Sail J. R., . Lifetest procedure. SAS Users Guide: Statistics Version 5 ed. Raleigh, J.T Hewig, K. Cornseil, et al. SAS Institute, NC 1986; 529–558
- Brunner F., Broyer M., Brynger H., Challah S., Fassbinder W., Riz-zoni G., Selwood N., Wing A. Combined report on regular dialysis and transplantation in Europe. XV. Proc EDTA-ERA 1985; 22: 5–79
- Weinrauch L., D'Elia J., Healy R., Gleason R., Takacs F., Libertino J., Leland O., Jr. Asymptomatic coronary artery disease: Angiog-raphy in diabetic patients before renal transplantation; a relationship of findings to post-operative survival. Ann Intern Med 1978; 88: 346–348
- Philipson J., Carpenter B., Itzkoff J., Hakala T., Rosenthal J., Taylor R., Puschett J. Evaluation of cardiovascular risk for renal transplantation in diabetic patients. Am J Med 1986; 81: 630–634
- Kjellstrand C., Matson M. Long-term follow up of 369 patients undergoing dialysis. Arch Intern Med 1988; 148: 600–604
- Weinrauch L., D'Elia, Gleason R., Hampton L., Smith-Ossman S., DeSilva R., Nesto R. Usefulness of left ventricular size and function in predicting survival in chronic dialysis patients with diabetes mellitus. Am J Cardiol 1992; 70: 300–303
- Gordon T., Castelli W., Hjortland M., Kannel W., Dawber T. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977; 62: 707–714
- The Expert Panel. Report of the national cholesterol education program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 1988; 148: 36–69
- Wilson P., Christiansen J., Anderson K., Kannel W. Impact of national guidelines for cholesterol risk factor screening—the Framingham offspring study. J Am Med Assoc 1989; 262: 41–44
- Laffel L., Warram J., Krolewski A. Cardiovascular mortality in patients with early diabetic nephropathy. Kidney Int 1990; 37: 241, (abstract)
- Neaton J. D., Wentworth D. For the multiple risk factor intervention trial reserach group. Arch Intern Med 1992; 152: 56–64
- Vaziri N. B., Risk C., Hartin D. C., Novey HS. Comparison of hyperlipidemia in dialysis patients, renal transplant recipients, and steroid treated nonrenal patients. J Dialysis 1980; 4: 63–71